6-Iodo-4-Hydroxyquinazoline CAS 16064-08-7 Purity > 98.5% (HPLC) Hoobkas

Lus piav qhia luv luv:

Lub npe tshuaj: 6-Iodo-4-Hydroxyquinazoline

CAS: 16064-08-7 Nr

Purity:> 98.5% (HPLC)

Cov tsos mob: daj ntseg daj rau xim av Crystal hmoov

API API (CAS: 388082-78-8)

Hu rau: Dr. Alvin Huang

Txawb/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com 


Product Detail

Yam khoom

Khoom cim npe

Lapatinib Intermediates:

Chemical Properties:

Tshuaj npe 6-Iodo-4-Hydroxyquinazoline
Synonyms 6-Iodoquinazolin-4-ib qho;6-Iodo-4-Quinazolinone;6-Iodoquinazolin-4 (3H) - ib qho;6-Iodo-4(1H)-Quinazolinone;6-Iodo-4-Quinazolinol
CAS Nr 16064-08-7
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C8H5IN2O
Molecular Luj 272.04 Nws
Melting Point 271 ℃ (lit.)
Qhov ntom 2.11 ± 0.10g / cm3
COA & MSDS Muaj
Keeb kwm Shanghai, Suav
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications Specifications
Qhov tshwm sim Pale Yellow rau Brown Crystal Ua raws
Kev txheeb xyuas H-NMR, MS Ua raws
Poob rau ziab <1.00% 0.45%
Residue ntawm Ignition <0.10% <0.10%
Purity / Analysis Method > 98.5% (HPLC) 98.79% (HPLC)
1 H NMR Spectrum Raws li tus qauv Ua raws
Test Standard Enterprise Standard  
Kev siv API API (CAS: 388082-78-8) 

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

www.ruifuchem.com

16064-08-7 - Kev pheej hmoo thiab kev nyab xeeb:

Risk Codes
36 - Kho qhov muag
Kev nyab xeeb piav qhia
26 - Thaum sib cuag nrog lub qhov muag, yaug tam sim ntawd nrog dej txaus thiab nrhiav kev kho mob.

16064-08-7 - Daim ntawv thov:

6-Iodo-4-Hydroxyquinazoline (CAS: 16064-08-7) yog ib qho nruab nrab hauv kev sib txuas ntawm API (CAS: 388082-78-8).(CAS: 388082-78-8) muaj nyob rau hauv 250-mg ntsiav tshuaj rau kev tswj qhov ncauj thiab yog siv ua ke nrog Cabecitabine hauv kev kho mob qog noj ntshav rau cov neeg mob uas tshaj tawm hom 2 EGF-R thiab cov uas yav tas los tau txaistaxane, anthracycline, thiab kev kho mob trastuzumab.Hom 2EGF-R yog ib qho subtype ntawm cov receptor no thiab tseem hu ua HER2 lossis ErbB-2.Tus neeg sawv cev yog receptor TK inhibitor tsom rau ErbB-1 thiab ErbB-2 subtypes.

Sau koj cov lus ntawm no thiab xa tuaj rau peb